We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
all report title image
  • Published On : Jul 2021
  • Code : CMI4508
  • Pages : 148
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical
Ingographics Image

Liposomal doxorubicin is a chemotherapy drug, which is administered intravenously to treat AIDS-related Kaposi's sarcoma, breast cancer, ovarian cancer, and other solid tumors. Doxorubicin acts by blocking an enzyme called topoisomerase 2 that cancer cells need in order to divide and grow. Liposomal delivery of doxorubicin HCL (Hydrochloride) improves drug penetration into tumors and decreases drug clearance, thereby increasing the duration of therapeutic drug effects. Some side effects of using Doxil or doxorubicin hydrochloride liposome include low blood counts, hand-to-foot syndrome (palmar-plantar erythrodysesthesia), mouth sores, infusion-related side effects: shortness of breath, facial swelling, headache, back pain, flushing, tightness in the chest and throat, and/or low blood pressure.

Market Dynamics

The increasing prevalence of cancer is expected to drive demand for liposomal doxorubicin for treatment of the disease and aid in growth of the U.S. liposomal doxorubicin market. For instance, according to the American Cancer Society, in 2017, cancer was the second most common cause of death in the U.S., and accounted for nearly one out of four deaths. Moreover, according to National Cancer Institute, in 2019, around 1.8 million people were diagnosed with cancer in the U.S., and around 276,480 women and 2,670 men were diagnosed with breast cancer.

Key features of the study:

  • This report provides in-depth analysis of the U.S. liposomal doxorubicin market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020-2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the U.S. liposomal doxorubicin market based on the following parameters – company highlights, types portfolio, key highlights, financial performance, and market strategies
  • Key companies covered as a part of this study include Johnson & Johnson, Baxter International Inc., Sun Pharmaceutical Industries Ltd., and Dr. Reddy’s Laboratories, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The U.S. liposomal doxorubicin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.S. liposomal doxorubicin market

Detailed Segmentation:

  • U.S. Liposomal Doxorubicin Market, By Drug Type:
    • Branded
    • Generic
  • U.S. Liposomal Doxorubicin Market, By Cancer Type:
    • Ovarian Cancer
      • AIDS-related Kaposi’s Sarcoma
      • Multiple Myeloma
      • Others
  • U.S. Liposomal Doxorubicin Market, By States:
    • California
    • Texas
    • Florida
    • New York
    • Pennsylvania
    • Illinois
    • Ohio
    • Georgia
    • North Carolina
    • Michigan
    • New Jersey
    • Virginia
    • Washington
    • Arizona
    • Others
  • Company Profiles
    • Johnson & Johnson*
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Baxter International Inc.
    • Sun Pharmaceutical Industries Ltd.
    • Reddy’s Laboratories, Inc.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Drug Type
      • Market Snapshot, By Cancer Type
      • Market Snapshot, By States
      • Market Opportunity Map
  3. U.S. Liposomal Doxorubicin Market Insights
    • Drivers
    • Restraints
    • Opportunity
    • Impact Analysis
    • Demand Analysis
    • Regulatory Scenario
    • Key Developments
    • PEST Analysis
    • Pricing Analysis
    • Competitive Snapshot
    • Pipeline Analysis
    • Major Distributors
    • Reimbursement Scenario
    • Epidemiology
    • Alternative Treatments
    • Liposomal Doxorubicin Import and Export
  4. Global Liposomal Doxorubicin Market Overview
    • Definition
    • Impact Analysis
    • Market Overview
    • Regional Share
    • S. & Global Market Comparison
  5. U.S. Liposomal Doxorubicin Market - Impact of Coronavirus (Covid-19) Pandemic
    • Impact on Supply Chain
    • Impact on Demand
  6. U.S. Liposomal Doxorubicin Market, By Drug Type, 2016 – 2027 (US$ Million)
    • Introduction
      • Market Share Analysis, 2020 and 2027(%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Branded
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027(US$ Million)
    • Generic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027(US$ Million)
  7. U.S. Liposomal Doxorubicin Market, By Cancer Type, 2016 – 2027 (US$ Million)
    • Introduction
      • Market Share Analysis, 2020 and 2027(%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Ovarian Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027(US$ Million)
    • AIDS-related Kaposi’s Sarcoma
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027(US$ Million
    • Multiple Myeloma
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027(US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027(US$ Million)
  8. U.S. Liposomal Doxorubicin Market, By States, 2016 – 2027 (US$ Million)
    • Introduction
      • Market Share Analysis, 2020 and 2027(%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Country at Trends
    • California
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Million)
    • Texas
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Million)
    • Florida
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Million)
    • New York
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Million)
    • Pennsylvania
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Million)
    • Illinois
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Million)
    • Ohio
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Million)
    • Georgia
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Million)
    • North Carolina
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Million)
    • Michigan
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Million)
    • New Jersey
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Million)
    • Virginia
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Million)
    • Washington
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Million)
    • Arizona
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Million)
  9. Company Profiles
    • Johnson & Johnson
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Baxter International Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Sun Pharmaceutical Industries Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Reddy’s Laboratories, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
  10. Section
    • Research Methodology
    • About us
    • Contacts

*Browse 9 market data tables and 29 figures on "liposomal doxorubicin market” – U.S. forecast to 2027

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
  • Want to Buy a Report but have a Limited Budget?

    We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

    Request Discount
Logo

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo